Two studies published in the Annals of Internal Medicine indicate that Medtronic significantly overstated the safety of its Infuse bone graft product. An independent study conducted at Yale revealed that

In our last post we discussed the pending litigation against one of the nation’s largest medical device manufacturers arising out of the off-label use of its bone grafts. Medtronic’s INFUSE

When the makers of a drug or medical device pay doctors to provide research on the safety and efficacy of the treatment, can the results be trusted? In the case